DSpace Repository

Identification of clinical phenotypes and related survival in patients with large hccs

Show simple item record

dc.contributor.author Carr, B.I.
dc.contributor.author Guerra, V.
dc.contributor.author Donghia, R.
dc.contributor.author Farinati, F.
dc.contributor.author Giannini, E.G.
dc.contributor.author Muratori, L.
dc.contributor.author Rapaccini, G.L.
dc.contributor.author Di Marco, M.
dc.contributor.author Caturelli, E.
dc.contributor.author Zoli, M.
dc.contributor.author Sacco, R.
dc.contributor.author Celsa, C.
dc.contributor.author Campani, C.
dc.contributor.author Mega, A.
dc.contributor.author Guarino, M.
dc.contributor.author Gasbarrini, A.
dc.contributor.author Svegliati-Baroni, G.
dc.contributor.author Foschi, F.G.
dc.contributor.author Biasini, E.
dc.contributor.author Masotto, A.
dc.contributor.author Nardone, G.
dc.contributor.author Raimondo, G.
dc.contributor.author Azzaroli, F.
dc.contributor.author Vidili, G.
dc.contributor.author Brunetto, M.R.
dc.contributor.author Trevisani, F.
dc.date.accessioned 2022-10-06T12:50:00Z
dc.date.available 2022-10-06T12:50:00Z
dc.date.issued 2021
dc.identifier.issn 20726694 (ISSN)
dc.identifier.uri http://hdl.handle.net/11616/71620
dc.description.abstract Background. Hepatocellular carcinoma (HCC) factors, especially maximum tumor diameter (MTD), tumor multifocality, portal vein thrombosis (PVT), and serum alpha-fetoprotein (AFP), influence survival. Aim. To examine patterns of tumor factors in large HCC patients. Methods. A database of large HCC patients was examined. Results. A multiple Cox proportional hazard model on death identified low serum albumin levels and the presence of PVT and multifocality, with each having a hazard ratio ≥2.0. All combinations of these three parameters were examined in relation to survival. Using univariate Cox analysis, the combination of albumin >3.5 g/dL and the absence of both PVT and multifocality had the best survival rate, while all combinations that included the presence of PVT had poor survival and hazard ratios. We identified four clinical phenotypes, each with a distinct median survival: patients with or without PVT or multifocality plus serum albumin ≥3.5 (g/dL), with each subgroup displaying high (≥100 IU/mL) or low (<100 IU/mL) blood AFP levels. Across a range of MTDs, we identified only two significant trends, blood AFP and platelets. Conclusions. Patients with large HCCs have distinct phenotypes and survival, as identified by the combination of PVT, multifocality, and blood albumin levels. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.source Cancers
dc.title Identification of clinical phenotypes and related survival in patients with large hccs


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record